Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF JUNE 1,2000 PSA#2612

National Cancer Institute, Research Contracts Branch, PSAS, 6120 Executive Blvd, EPS/Room 638, Bethesda, MD 20892-7227

A -- PATHOLOGY REVIEW SERVICES SOL NCI-RFQ-00132-NR DUE 061600 POC Marsha Gorham, Purchasing Agent, (301)402-4509 & Gail Zois, Contracting Officer The National Cancer Institute(NCI), Division of Cancer Epidemiology and Genetics (DCEG), Environmental Epidemiology Branch plans to procure pathology review services from Kaiser Foundation Research Institution, Center for Health Research, 1800 Harrison Street, 16th Floor, Oakland, CA 94612. NCI has been conducting a cohort study of human papillomavirus (HPV) infection and cervical cancer since 1989. A previous research contract with Kaiser Foundation was in place until 1994 for the more extensive portion of the study. In 1999, a follow-up for record reviews of the Portland cohort (300 records) was performed for the period 1995 to 1999 under a purchase order. Based on that review, the NCI researcher determined that pathology review of the records for those cases identified last year is worthwhile. The review will be conducted by the Kaiser Permanente pathology collaborator, Dr. Scott, and staff. Kaiser Permanente staff completed computer searches that identified the relevant women within the HPV study population. From the initial work, Kaiser has collected specimens, controls, calculation rates, cyto- and histopathology slides from suspect cases. Using these materials/items, Kaiser can process the pathology reviews of all new cases that were followed up. All procedures, which were developed and utilized under the initial contract, shall be followed to insure continuity and consistency between the previous data and new data, as well as the overall analyses. There is no other source known by the NCI researcher that can perform the above reviews since Kaiser has all the required clinical materials (slides, controls, and data) and access to the required clinical databases for the overall study. A change in the source will prevent continuity with the previous study and affect study variables. This is not a request for competitive quotation. However, if any interested party believes it can perform the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform this requirement without compromising the integrity of the overall. Capability statements must be received in the contracting office by 3:00 p.m. EST, on June 16, 2000. If you have any questions, please contact Marsha Gorham, Purchasing Agent on (301) 402-4509. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Please cite the solicitation number NCI-RFQ-00132-NR. Posted 05/30/00 (W-SN459631). (0151)

Loren Data Corp. http://www.ld.com (SYN# 0003 20000601\A-0003.SOL)


A - Research and Development Index Page